Goldman Sachs’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Buy |
96,841
+48,112
| +99% | +$129K | ﹤0.01% | 4596 |
|
|
2025
Q1 | $209K | Sell |
48,729
-13,408
| -22% | -$57.4K | ﹤0.01% | 4663 |
|
|
2024
Q4 | $249K | Buy |
62,137
+20,098
| +48% | +$80.4K | ﹤0.01% | 4589 |
|
|
2024
Q3 | $216K | Buy |
+42,039
| New | +$216K | ﹤0.01% | 4465 |
|
|
2022
Q3 | – | Sell |
-94,036
| Closed | -$937K | – | 5605 |
|
|
2022
Q2 | $937K | Buy |
94,036
+35,700
| +61% | +$356K | ﹤0.01% | 3992 |
|
|
2022
Q1 | $578K | Buy |
+58,336
| New | +$578K | ﹤0.01% | 4479 |
|